Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$389,760,132
+$69,802,543 QoQ
Shares Held
1,803,944
+3.4% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#13
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. BIIB ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,760,132 | 1,803,944 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $319,957,589 | 1,745,255 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $291,341,053 | 1,655,441 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $338,731,222 | 2,418,127 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $291,384,617 | 2,320,126 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $309,943,552 | 2,265,007 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $325,537,160 | 2,128,807 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $315,907,436 | 1,629,733 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $298,918,669 | 1,289,443 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $359,674,497 | 1,668,017 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $469,581,113 | 1,814,666 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $303,624,923 | 1,181,374 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $282,572,901 | 992,006 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $284,682,414 | 1,023,927 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $254,899,035 | 920,479 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $259,197,192 | 970,776 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $195,035,974 | 956,340 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $200,998,528 | 954,409 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $271,364,626 | 1,131,063 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $280,323,944 | 990,579 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $361,318,194 | 1,043,458 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $289,272,965 | 1,034,041 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $205,675,047 | 839,970 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $255,602,765 | 901,025 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $243,305,147 | 909,382 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $298,770,281 | 944,340 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||